SanaHeal won Critical Care Innovation Incubator Pitch Competition sponsored by MTEC
SCCM C2I2
Hyunwoo Yuk
SanaHeal won Execution Award by MedTech Innovator during MedTech Conference in Toronto
MedTech Innovator
SanaHeal is awarded $2.5M NIH NHLBI SBIR Direct-to-Phase II grant in collaboration with Mayo Clinic and BWH, Harvard Medical School for commercialization of the next-generation solution for surgical bleeding control.
Grant Award
SanaHeal is selected to participate 2024 Ray of Hope Accelerator cohort
Biomimicry Institute
SanaHeal won the first prize for 2024 iCANX Startup Award
iCANX Startup Award
SanaHeal is selected to participate 2024 MedTech Innovator cohort
MedTech Innovator
SanaHeal’s patents for on-demand detachable bioadhesive and strain-programmable bioadhesive are issued in the U.S.
Patent Issuance
SanaHeal’s patents for bioadhesive patch and paste are issued in the U.S.
Patent Issuance
SanaHeal is awarded $2.3M NIH NIDDK SBIR Direct-to-Phase II grant in collaboration with BIDMC, Harvard Medical School for commercialization of the next-generation solution for diabetic wounds and ulcers.
Grant Award